Circ_0027885 sponges miR-203-3p to regulate RUNX2 expression and alleviates osteoporosis progression

Shuhua Fang,Dingwen Cao,Zhanpo Wu,Jie Chen,Yafei Huang,Ying Shen,Zengxin Gao
DOI: https://doi.org/10.1186/s12891-023-07122-1
IF: 2.562
2024-01-02
BMC Musculoskeletal Disorders
Abstract:Abstract Background Osteoporosis (OP) is a progressive metabolic disorder that is difficult to cure clinically. The molecular mechanisms of OP urgently need to be further examined. This study was designed to explore the potential function of circ_0027885 during osteogenic differentiation, as well as the systematic interactions among circ_0027885, miR-203-3p and runt-related transcription factor 2 (RUNX2). Methods Relative levels of circ_0027885, miR-203-3p and RUNX2 were analyzed with RT-qPCR and western blotting. Alizarin red staining was performed to detect the mineralization ability under the control of circ_0027885 and miR-203-3p. Dual-luciferase reporter gene assay was conducted to examine the combination among circ_0027885, miR-203-3p and RUNX2. Results Our research demonstrated that circ_0027885 was significantly increased during hBMSCs differentiation. Overexpression of circ_0027885 notably facilitated osteogenic differentiation and upregulated RUNX2 expression, while knockdown of circ_0027885 reversed the above results. Through prediction on bioinformatics analysis, miR-203-3p was the target binding circ_0027885, and RUNX2 was the potential target of miR-203-3p. Subsequently, these changes induced by the overexpression of circ_0027885 were reversed upon addition of miR-203-3p mimic. Conclusions Circ_0027885 could sponge miR-203-3p to regulate RUNX2 expression and alleviate osteoporosis progression.
orthopedics,rheumatology
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the potential function of circular RNA (circRNA) circ_0027885 in the osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs) and its systemic interaction with miR-203-3p and RUNX2. Specifically, the study aims to reveal whether circ_0027885 regulates the expression of RUNX2 by acting as a competitive endogenous RNA (ceRNA) for miR-203-3p, thereby affecting the progression of osteoporosis (OP). The research background indicates that osteoporosis is a multifactorial skeletal disease characterized by increased bone fragility and reduced bone density. This disease severely impacts the quality of life of patients and increases the risk of disability and mortality, especially in the elderly and postmenopausal women. Currently, the treatment options for osteoporosis are limited, mainly including physical therapy, exercise therapy, and medication. Therefore, in-depth research into the molecular genetic mechanisms of osteoporosis is of great significance for the prevention and alleviation of the disease. Through experimental studies, the authors found that circ_0027885 was significantly upregulated during the osteogenic differentiation of hBMSCs. Overexpression of circ_0027885 promoted osteogenic differentiation and upregulated the expression of RUNX2, while inhibition of circ_0027885 reversed these effects. Bioinformatics analysis predicted that miR-203-3p is a target of circ_0027885, and RUNX2 is a potential target of miR-203-3p. Further experiments showed that the changes induced by overexpression of circ_0027885 were reversed after the addition of miR-203-3p mimics. In summary, this study is the first to identify a new molecular mechanism by which circ_0027885 regulates RUNX2 expression by sponging miR-203-3p. This mechanism may help promote the osteogenic differentiation of hBMSCs, thereby alleviating the progression of osteoporosis.